Click-engineered codeine derivatives: modulating pharmacological activity via 1,2,3-triazole tethering.

The structural modification of morphinan alkaloids remains a vital strategy for developing therapeutics with optimized efficacy and reduced side effects. Herein, we report the rational design and synthesis of a novel library of seventeen 1,4-disubstituted 1,2,3-triazole-tethered codeine derivatives (13a-13q). Utilizing a highly efficient copper-catalyzed alkyne-azide cycloaddition (CuAAC) strategy, these structurally diverse derivatives were synthesized in good to excellent yields (66-86%) under mild, room-temperature conditions within exceptionally short reaction times (12-23 min). The therapeutic potential of the library was evaluated in vivo using formalin-induced paw edema and acute tail-flick models to determine peripheral anti-inflammatory and central antinociceptive profiles, respectively. The resulting pharmacological profiles demonstrate that the electronic and steric properties of the triazole substituents heavily dictate therapeutic outcomes. Central antinociceptive efficacy was favored by electron density, with the 3,4-dimethoxy phenyl derivative 13j (7.03 ± 1.53) significantly outperforming both standard sodium diclofenac and the parent codeine scaffold. Conversely, peripheral anti-inflammatory activity was optimized by specific halogenated and aliphatic architectures, with derivatives 13l, 13e, and 13n exhibiting the most pronounced edema mitigation, while the allyloxy-containing derivative 13q induced a significant pro-inflammatory response. These findings establish triazole tethering at the codeine hydroxyl group as a promising scaffold for the development of dual-action anti-inflammatory and antinociceptive agents.